What is the price target for LUCD stock?
11 analysts have analysed LUCD and the average price target is 4.18 USD. This implies a price increase of 283.67% is expected in the next year compared to the current price of 1.09.
NASDAQ:LUCD • US54948X1090
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for LUCID DIAGNOSTICS INC (LUCD).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-09 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2026-03-30 | BTIG | Reiterate | Buy -> Buy |
| 2026-03-26 | Needham | Reiterate | Buy -> Buy |
| 2025-12-10 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-11-13 | Needham | Reiterate | Buy -> Buy |
| 2025-10-06 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-09-10 | BTIG | Reiterate | Buy -> Buy |
| 2025-09-05 | BTIG | Maintains | Buy -> Buy |
| 2025-08-13 | Needham | Reiterate | Buy -> Buy |
| 2025-07-16 | Needham | Reiterate | Buy -> Buy |
| 2025-06-06 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-05-15 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-05-14 | Needham | Reiterate | Buy -> Buy |
| 2025-04-21 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-04-11 | Needham | Reiterate | Buy -> Buy |
| 2025-03-26 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-03-24 | Needham | Maintains | Buy -> Buy |
| 2024-12-09 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-11-15 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-11-14 | Needham | Reiterate | Buy -> Buy |
| 2024-11-14 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-09-10 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-08-13 | Needham | Reiterate | Buy -> Buy |
| 2024-08-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-06-06 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.428M 538.95% | 4.346M 79.00% | 4.706M 8.28% | 10.145M 115.58% | 23.388M 130.54% | 29.274M 25.17% | 42.84M 46.34% | 59.976M 40.00% | 80.988M 35.03% | 105.26M 29.97% | 131.58M 25.00% | |
| EBITDA YoY % growth | -45.983M 15.21% | -44.885M 2.39% | -48.768M -8.65% | -44.931M 7.87% | -37.536M 16.46% | -42.738M -13.86% | -35.088M 17.90% | -23.766M 32.27% | -9.18M 61.37% | N/A | N/A | |
| EBIT YoY % growth | -48.482M 13.69% | -46.052M 5.01% | -49.64M -7.79% | -44.233M 10.89% | -36.633M 17.18% | -27.714M 24.34% | -40.188M -45.01% | -29.886M 25.63% | -16.32M 45.39% | -2.142M 86.88% | 17.34M 909.52% | |
| Operating Margin | -1,996.79% | -1,059.64% | -1,054.82% | -436.01% | -156.63% | -94.67% | -93.81% | -49.83% | -20.15% | -2.03% | 13.18% | |
| EPS YoY % growth | -1.22 11.59% | -1.06 13.11% | -0.80 24.53% | -0.28 65.49% | -0.21 23.65% | -0.18 12.90% | -0.13 27.78% | -0.09 30.77% | -0.04 55.56% | N/A | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.08 83.72% | -0.07 6.93% | -0.07 32.68% | -0.06 40.16% | -0.06 30.12% | -0.06 22.84% | -0.05 27.27% | -0.04 30.68% |
| Revenue Q2Q % growth | 1.411M 70.41% | 1.818M 56.32% | 2.984M 146.41% | 3.933M 161.50% | 4.216M 198.80% | 5.202M 186.14% | 6.936M 132.44% | 8.228M 109.20% |
| EBITDA Q2Q % growth | -11.152M 9.08% | -11.016M -0.69% | -10.608M 4.40% | -10.064M 23.40% | -9.996M 10.37% | -9.554M 13.27% | -8.738M 17.63% | -8.024M 20.27% |
| EBIT Q2Q % growth | -12.652M -1.32% | -12.507M -9.86% | -12.096M -2.86% | -11.624M 17.04% | -11.186M 11.58% | -10.744M 14.09% | -9.894M 18.20% | -9.248M 20.44% |
All data in USD
11 analysts have analysed LUCD and the average price target is 4.18 USD. This implies a price increase of 283.67% is expected in the next year compared to the current price of 1.09.
LUCID DIAGNOSTICS INC (LUCD) will report earnings on 2026-05-12, before the market open.
The consensus EPS estimate for the next earnings of LUCID DIAGNOSTICS INC (LUCD) is -0.08 USD and the consensus revenue estimate is 1.41M USD.
The expected long term growth rate for LUCID DIAGNOSTICS INC (LUCD) is 84.62%.